Evidence map›Paper›PMID 34877444›Full record

ArticleJournal of the Endocrine Society2021

Depot Pure GnRH Antagonist for Long-term Treatment of Ovarian Hyperthecosis Monitored by Multisteroid LCMS Profiling.

Huajing Ni, Robert Schmidli, Sasha Savkovic, Simone I Strasser, Julie Hetherington, Reena Desai, David J Handelsman

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of the Endocrine Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Huajing NiDepartment of Andrology, Concord Hospital, Sydney, Australia.ORCID https://orcid.org/0000-0002-7109-9680
Robert SchmidliDepartment of Endocrinology, Canberra Hospital, Canberra, Australia.ORCID https://orcid.org/0000-0003-3800-6603
Sasha SavkovicDepartment of Andrology, Concord Hospital, Sydney, Australia.
Simone I StrasserAW Morrow Gastroenterology & Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia.
Julie HetheringtonDepartment of Endocrinology, Royal Prince Alfred Hospital, Sydney, Australia.
Reena DesaiANZAC Research Institute, University of Sydney, Sydney, Australia.
David J HandelsmanDepartment of Andrology, Concord Hospital, Sydney, Australia.ORCID https://orcid.org/0000-0002-4200-7476
Concord Repatriation General Hospital · AURoyal Prince Alfred Hospital · AUThe University of Sydney · AUCanberra Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian hyperthecosis (OHT), severe hyperandrogenism after menopause in the absence of ovarian or adrenal tumors, is usually treated by surgical excision. We report a 58-year-old woman presenting with severe hyperandrogenism (serum testosterone 15.7-31.0 nmol/L, normal female <1.8 nmol/L) with menopausal gonadotropins and virilization but no adrenal or ovarian lesions. Multisteroid profiling by liquid chromatography mass spectrometry (LCMS) of adrenal and ovarian vein samples identified strong gradients in the left ovarian vein (10- to 30-fold vs peripheral blood in 17OHP

Indexed as

GnRH antagonistliquid chromatography mass spectrometryovarian hyperthecosisovarian vein samplingsteroid profiletestosterone

Identifiers

PMID34877444
PMCPMC8645162
OpenAlexW3213775590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.